Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2021-05-18 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
上海市通力律师事务所关于无锡祥生医疗科技股份有限公司2020年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a legal opinion letter issued by a law firm regarding the 2020 Annual General Meeting (AGM) of Wuxi Xiangsheng Medical Technology Co., Ltd. It discusses the legality and compliance of the AGM's convening, attendance, voting procedures, and results. The document does not contain financial statements or detailed financial performance data, nor is it an announcement of the AGM or voting results. Instead, it is a legal opinion related to the AGM process. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA) because it pertains to the official validation and legal opinion on the AGM voting results and procedures.
2021-05-18 Chinese
上海市通力律师事务所关于无锡祥生医疗科技股份有限公司2021年限制性股票激励计划首次授予相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's 2021 restricted stock incentive plan first grant. It discusses the approval, authorization, grant date, grant conditions, and compliance with relevant laws and regulations. It is not a financial report, earnings release, or management discussion. It is a legal opinion related to a capital incentive plan (stock-based compensation). This type of document is best classified under Regulatory Filings (RNS) as it is a legal compliance document and does not fit other categories like Remuneration Information (DEF 14A) which typically details compensation amounts, or Capital/Financing Update (CAP) which relates to fundraising or capital structure changes. The document is about legal compliance and authorization for a stock incentive plan grant, so RNS is the most appropriate category.
2021-05-18 Chinese
祥生医疗关于召开2020年度业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the scheduling and details of a 2020 annual performance explanation meeting (业绩说明会) for investors. It references that the 2020 Annual Report has already been disclosed on April 24, 2021, and invites investors to participate in a web-based interactive session to discuss the company's 2020 annual results. The document does not contain actual financial data or detailed financial statements but serves as a notice for the upcoming performance explanation meeting. Given the document length (1246 characters) and content, it is an announcement related to an investor presentation or earnings call but not the transcript or the report itself. The best fitting category is Investor Presentation (IP), as it is a detailed presentation for investors focusing on financials and company performance, even though the actual presentation will occur later. The document is not a full call transcript (CT) or earnings release (ER) since it is a notice of the meeting, not the results or transcript. Therefore, classify as Investor Presentation (IP) with high confidence.
2021-05-11 Chinese
无锡祥生医疗科技股份有限公司2020年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "无锡祥生医疗科技股份有限公司 2020 年年度股东大会会议资料" which translates to "Wuxi Xiangsheng Medical Technology Co., Ltd. 2020 Annual General Meeting Materials." It contains detailed information about the 2020 Annual General Meeting (AGM), including meeting notices, agenda, voting procedures, and various proposals to be discussed and voted on during the AGM. The content includes instructions for shareholders, meeting schedules, and detailed descriptions of agenda items such as approval of the 2020 annual report, board work report, remuneration plans, audit firm appointment, profit distribution, financial reports, and other corporate governance matters. The document is clearly a presentation or materials prepared for the AGM, not the actual annual report or other filings. It is lengthy (15,000 characters) and contains detailed meeting materials, consistent with the definition of AGM Information (AGM-R). Therefore, the correct classification is AGM Information (AGM-R).
2021-05-11 Chinese
祥生医疗监事会关于公司2021年限制性股票激励计划激励对象名单的公示情况说明及核查意见
Regulatory Filings Classification · 95% confidence The document is a public announcement by the supervisory board of Wuxi Xiangsheng Medical Technology Co., Ltd. regarding the disclosure and verification of the list of incentive recipients under the company's 2021 restricted stock incentive plan. It includes details about the internal and external disclosure process, compliance with relevant laws and regulations, and the supervisory board's verification opinion. The document does not contain financial statements or detailed financial data but is an official announcement related to the company's stock incentive plan and compliance verification. It is not a full report like an annual or interim report, nor is it a call transcript or earnings release. It is also not a remuneration report detailing compensation amounts but rather a formal announcement about the incentive plan participants and the supervisory board's opinion. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-05-11 Chinese
祥生医疗关于预计2021年度日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected daily related-party transactions for the fiscal year 2021 by Wuxi Xiangsheng Medical Technology Co., Ltd. It details the nature, amount, and approval process of these related-party transactions, including independent directors' opinions and the sponsor's verification. The document explicitly states that the transactions are routine, based on market prices, and do not require shareholder meeting approval. It is a regulatory announcement about related-party transactions rather than a financial report or audit. The document length is about 3103 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Regulatory Filings (RNS), as it is a compliance disclosure about related-party transactions without substantive financial statements or detailed financial analysis.
2021-04-23 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.